V023-1447 Screening compound: N-cyclopropyl-N-({5-[(2-fluorophenyl)methyl]-1-(2-methoxyphenyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)cyclopentanecarboxamide

V023-1447 Screening compound: N-cyclopropyl-N-({5-[(2-fluorophenyl)methyl]-1-(2-methoxyphenyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)cyclopentanecarboxamide
V023-1447 Screening compound: N-cyclopropyl-N-({5-[(2-fluorophenyl)methyl]-1-(2-methoxyphenyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)cyclopentanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-1447
N-cyclopropyl-N-({5-[(2-fluorophenyl)methyl]-1-(2-methoxyphenyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)cyclopentanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-1447

Molecular Formula

C30H35FN4O2 (C30 H35 FN4 O2)

Compound Name

N-cyclopropyl-N-({5-[(2-fluorophenyl)methyl]-1-(2-methoxyphenyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)cyclopentanecarboxamide

IUPAC name

N-cyclopropyl-N-({5-[(2-fluorophenyl)methyl]-1-(2-methoxyphenyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl}methyl)cyclopentanecarboxamide

SMILES

COc(cccc1)c1-n1nc(CN(C2CC2)C(C2CCCC2)=O)c2c1CCN(Cc(cccc1)c1F)C2

InChI

InChI=1S/C30H35FN4O2/c1-37-29-13-7-6-12-28(29)35-27-16-17-33(18-22-10-4-5-11-25(22)31)19-24(27)26(32-35)20-34(23-14-15-23)30(36)21-8-2-3-9-21/h4-7,10-13,21,23H,2-3,8-9,14-20H2,1H3

InChI Key

WWBUICFSGUPACD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19934922

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

502.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.211

Distribution Coefficient, logD

1.962

Water Solubility, LogSw

-5.04

Polar Surface Area

42.127

Acid Dissociation Constant (pKa)

22.71

Base Dissociation Constant (pKb)

10.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.70

V023-1447 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V023-1447 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-1447?
Check Price and Availability of V023-1447, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-1447 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-1447
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-1447
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-1447 available by request